HIGHLIGHTS
- who: Maria Davern from the Department of Surgery, Trinity StJames's Cancer Institute, Trinity Translational Medicine Institute, St. James's Hospital, Trinity College Dublin, Dublin, Ireland have published the Article: FLOT and CROSS chemotherapy regimens alter the frequency of CD27+ and CD69+ T cells in oesophagogastric adenocarcinomas: implications for combination with immunotherapy, in the Journal: (JOURNAL)
- what: This study investigates the immunostimulatory properties of FLOT CROSS and MAGIC chemotherapy regimens in the context of OGJ using in vitro and ex vivo models of the treatment-naïve and post-chemotherapy treated tumour microenvironment. The effects . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.